Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Background: Deficits in emotion recognition have been shown to be closely related to social-cognitive functioning in schizophrenic. This study aimed to investigate the event-related potential (ERP) characteristics of social perception in schizophrenia patients and to explore the neural mechanisms underlying these abnormal cognitive processes related to social perception.
Methods: Participants included 33 schizophrenia patients and 35 healthy controls (HCs). All participants underwent electroencephalogram recording while completing the Emotion Intensity Recognition Task (EIRT). Behavioral data and ERP components were analyzed using repeated measures analysis of variance.
Results: Schizophrenia patients had longer reaction times (RTs) to sad faces compared with disgusted faces, and had lower accuracy than the HCs. Additionally, schizophrenia patients had lower accuracy than the HCs for disgusted faces, surprised faces, angry faces, and fearful faces. Late Positive Potential (LPP) mean amplitudes of the HCs were larger than the schizophrenia patients for sad faces in the frontal lobe and central lobe. For happy faces, the HCs elicited larger LPP mean amplitudes than schizophrenia patients in the frontal lobe and central lobe. For surprised faces, the LPP mean amplitudes were higher in the HCs in the central lobe and parietal lobe than in schizophrenia patients. The HCs exhibited larger LPP mean amplitudes for angry faces in the frontal lobe, central lobe, and parietal lobe than in schizophrenia patients. For fearful faces, the HCs elicited a larger LPP mean amplitude than schizophrenia patients in the frontal lobe, central lobe, and parietal lobe.
Conclusions: Schizophrenia patients present impaired social perception, and the observed ERP patterns provide valuable insights into the neural mechanisms underlying the EIRT results, highlighting the differences between HCs and schizophrenia patients. These findings underscore the potential of the EIRT as a biomarker for cognitive and emotional dysregulation in schizophrenia.
Clinical Trial Registration: No: ChiCTR2300078149. Registered 29 November, 2023; https://www.chictr.org.cn/showproj.html?proj=211510.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.31083/JIN25427 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Cognitive therapies and insight in early schizophrenia: A systematic review.
Encephale
September 2025
Université de Reims Champagne-Ardenne, C2S, Reims, France; Groupe Hospitalier Paul-Guiraud, GHT Psy Sud, Boulogne-Billancourt, France. Electronic address:
Objectives: This systematic review aims to evaluate the impact of cognitive-behavioral and metacognitive therapies on cognitive and clinical insight into early schizophrenia disease.
Methods: A comprehensive literature review was conducted across several databases, including Pubmed, PsycINFO, and Cochrane Library, focusing on studies published between 2006 and May 2024. The studies selected for this review were either randomized controlled trials (RCTs), cross-sectional studies, or exploratory studies.
Social isolation and its influencing factors among family caregivers of individuals with schizophrenia: A social-ecological systems theory perspective.
Schizophr Res
September 2025
School of Nursing, Bengbu Medical University, Bengbu, China. Electronic address:
Background: Social isolation adversely affects both physical and mental health. However, limited research has examined this issue among family caregivers of individuals with schizophrenia, particularly within a structured theoretical framework.
Objective: This study aimed to investigate the prevalence of social isolation and explore its associated multilevel factors among family caregivers of individuals with schizophrenia, guided by the Social-Ecological Systems Theory.
Transdiagnostic homogeneity, and diagnostic-specific biomarkers among major depressive disorder, bipolar disorder and schizophrenia during 40 Hz auditory steady-state response: a normative modeling analysis.
J Affect Disord
September 2025
Tianjin University, Medical School, Tianjin, China; Tianjin University, Haihe Laboratory of Brain-Computer Interaction and Human-Machine Integration, Tianjin, China; Tianjin University, State Key Laboratory of Advanced Medical Materials and Medical Devices, Tianjin, China.
Background: Abnormal gamma-band auditory steady-state response (gamma-ASSR) power has been reported in major depressive disorder (MDD), bipolar disorder (BD), and schizophrenia (SZ), but distinguishing between these disorders based solely on power remains challenging. Directed functional connectivity (DFC), which captures topological patterns of causal information flow, may provide more diagnostic-specific markers. However, conventional case-control framework often disregards the substantial individual heterogeneity, yielding unreliable biomarkers.
View Article and Find Full Text PDFClozapine-associated perturbation of arachidonic acid metabolism: A future direction for clozapine-induced cardiotoxicity.
Toxicol Lett
September 2025
Department of Pharmacology and Clinical Pharmacology, The University of Auckland, Private Bag 92019, Auckland 1142, New Zealand. Electronic address:
Clozapine is an effective antipsychotic medication utilised for treatment-resistant schizophrenia. However, clinical use of clozapine is limited due to the risk of cardiotoxicities, including clozapine-induced myocarditis. Oxidation of clozapine and reduction of clozapine-N-oxide can be catalysed by the cardio-selective cytochrome P450 (CYP) isoforms CYP2J2, CYP1A1 and CYP1B1, which are also reported to metabolise arachidonic acid.
View Article and Find Full Text PDFThe relationship between age of onset, peripheral plasma protein markers and social cognition in first-episode drug-naïve schizophrenia.
Schizophr Res
September 2025
Tianjin Anding Hospital, Mental Health Center, Tianjin Medical University, Tianjin, China. Electronic address:
Background: The relationship between age of onset and social cognition in schizophrenia (SCZ), as well as the role of peripheral plasma protein markers in this connection, remains unclear. This study aims to investigate these associations in first-episode drug-naïve SCZ.
Methods: A total of 171 SCZ patients were enrolled and categorized into non-late-onset and late-onset groups based on their age of onset, which was recorded at enrollment.